![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Mazor Robotics Snags CE Mark for Surgical Platform
Mazor Robotics Snags CE Mark for Surgical Platform
![Green_Light.gif](https://www.fdanews.com/ext/resources/test/Device_Images5/Green_Light.gif?t=1625610540&width=430)
September 21, 2017
Mazor Robotics, a Caesarea, Israel-based manufacturer of surgical robotic systems, announced it has received CE Mark approval for its Mazor X Surgical Assurance Platform.
The platform, which received 510(k) clearance as a Class II device in 2015, is a guidance system for spine surgery with 3-D planning tools, precision mechanics pre-op analytics software, and intraoperative surgical arm verification.
Mazor X will be marketed and sold in Europe by the company’s commercial partner Medtronic.
Upcoming Events
-
21Oct